Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Renato Rozental, MD PhD, CEO and Chief Scientific Officer of the Company, is a leading expert in the field of neuroscience. Dr. Rozental has developed a world-wide reputation over the last 16 years as a leading researcher into gap junction-mediated hypoxic-ischemic insults to the brain, spinal cord and retina.
Research interests include developmental neurobiology and diseases mediated by cell-cell communication via gap junction channels; impact of hypoxic-ischemic insults in the developing brain.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals